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Lysolecithin permeabilization of vaccinia virus-infected cells was employed to prepare extracts that support faithful
transcription initiation in vitro on plasmids possessing early, intermediate, and late viral gene promoters. Conditions which
optimize transcription from each promoter were defined. The in vitro system was used to investigate the multifunctional
viral mRNA capping enzyme, which also functions as the viral early gene transcription termination factor (VTF) and a viral
intermediate gene transcription initiation factor. A low level of signal-dependent termination of early gene transcription was
observed in vitro which could be elevated by the addition of pure mRNA capping enzyme. VTF-dependent transcription
termination was found to be restricted to templates that possessed an early promoter. This restriction mimics that observed
in vivo and demonstrates that transcription termination is limited to RNA polymerase molecules that recognize early rather
than intermediate or late gene promoters. Extracts prepared from cells infected at the nonpermissive temperature with a
virus containing a ts mutation in gene D12L, which encodes the small subunit of VTF, are incapable of supporting both
early gene transcription termination and intermediate gene transcription initiation. Both activities are restored upon addition
of the purified wild-type mRNA capping enzyme. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1987). VTF is also the vaccinia virus mRNA capping
enzyme. Intermediate gene transcription initiation em-
Poxviruses constitute a unique family of viruses that
ploys three protein factors; one has been identified as the
possess a double-stranded DNA genome yet conduct
viral mRNA capping enzyme, the second, a product oftheir replication cycle entirely within the cytoplasm of in-
gene E4L, and the third, a host protein (Vos et al., 1991;fected cells. Poxviruses have evolved to encode the en-
Rosales et al., 1994). Initiation of late gene transcriptionzymes required to carry out viral DNA replication, tran-
is dependent upon the synthesis of three intermediatescription, and mRNA processing (Moss, 1990a). Vaccinia,
proteins, the products of genes A1L, A2L, and G8R, andthe prototypic poxvirus, has a genome 191,686 bp in length
an additional unidentified early protein P (Keck et al., 1990;that contains approximately 200 genes (Goebel et al.,
Wright and Coroneos, 1993; Kovacs et al., 1994). The vac-1990). Gene expression is divided into three temporal
cinia virus RNA polymerase is a large multisubunit proteinclasses. Early genes are transcribed in the virus core
(Nevins and Joklik, 1977; Baroudy and Moss, 1980). Eachimmediately after infection; intermediate genes are tran-
subunit is encoded by a viral gene and several subunitsscribed subsequent to the onset of DNA replication and
show significant homology to subunits of eukaryotic RNArequire prior early gene expression; late gene transcrip-
Pol II (Broyles and Moss, 1986).tion follows the intermediate genes and requires the syn-
A genetic approach to investigating viral gene expres-thesis of three intermediate proteins (Moss, 1990b). This
sion is available to complement the ongoing biochemicaltemporal regulation of gene transcription is mediated by
studies. Collections exist of temperature-sensitive (ts) mu-the timed synthesis of class-specific transcription initiation
tations (Dales et al., 1978; Condit and Motyczka, 1981;factors. The vaccinia early gene transcription factor (VETF)
Ensinger, 1982; Condit et al., 1983; Ensinger and Rovinsky,is a heterodimer, derived from the D6R and A8L genes,
1983) that map to genes known to encode subunits of thewhich binds to early promoters upstream from the tran-
viral RNA polymerase (Ensinger, 1987; Thompson et al.,scription initiation site (Broyles et al., 1988; Broyles and
1989; Hooda-Dhingra et al., 1989, 1990), transcription initi-Fesler, 1990; Gershon and Moss, 1990). VTF, the vaccinia
ation factors (Christen et al., 1992; Carpenter and De-early gene transcription terminator, a different heterodimer
Lange, 1992), VTF (Carpenter and DeLange, 1991), andcomprising the D1R and D12L subunits, mediates signal-
other proteins known to play a role in viral gene expres-dependent termination of early RNA synthesis (Shuman
sion (Kane and Shuman, 1992; Simpson and Condit, 1994;
Black and Condit, 1996). In addition, reverse genetic ap-1 To whom correspondence and reprint requests should be addressed.
Fax: (716) 829-2725; E-mail: CAMEGN@UBVMSA.cc.buffalo.edu. proaches have been developed to either introduce ts mu-
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tations into (Hassett and Condit, 1994) or provide condi- Dr. Stewart Shuman. Accurate transcription of the pSB24
tional repression of any essential viral gene (Zhang et al., G-less cassette should yield an RNA of approximately
1992). To take full advantage of viral genetics it is neces- 380 nt in length. pCFW10 (Wright and Moss, 1989), which
sary to determine the biochemical consequences of each contains the vaccinia virus 11k (gene F17R) late promoter
mutation. Prior reports describe class-specific transcrip- placed upstream of the 375-nt G-less cassette in pC2AT19,
tion employing partially purified extracts of wild-type virus- was obtained from Dr. Cynthia Wright (Armed Forces Insti-
infected cells (Puckett and Moss, 1983; Foglesong, 1985; tute of Pathology, Washington, DC). Accurate transcription
Vos and Stunnenberg, 1988). To permit the facile biochem- of the pCFW10 G-less cassette should yield a 382-nucleo-
ical analysis of mutations in genes that affect viral gene side RNA which is subject to 5* polyadenylation.
expression a rapid means of preparing transcriptionally pVGFG, which contains the vaccinia virus growth fac-
active extracts of cells infected with virus at either the tor (VGF) (gene C11R) early promoter (Broyles et al., 1991)
permissive or the nonpermissive temperature was desir- placed upstream of the 375-nt G-less cassette in
able. Lysolecithin treatment of virus-infected cells has pC2AT19, was constructed as follows. Two complemen-
been employed in the past to generate soluble cyto- tary VGF promoter-containing oligonucleotides were syn-
plasmic extracts for analysis of RNA virus transcriptase thesized, 5* phosphorylated, annealed, and ligated to
and replicase activities (Peluso and Moyer, 1983; Carlsen pC2AT19 linearized with SacI and blunt ended with T4
et al., 1985; Moyer et al., 1990; Horikami and Moyer, 1991; DNA polymerase. The inserted oligonucleotide has the
Horikami et al., 1992) and for investigating translational sequence 5* AGTACTGTTTATATTACTGAATTAATAATA-
properties of poxvirus mRNA (Brown et al., 1983). TAAAATTCCCAATC 3*, where the plain text represents
In this report we describe an approach to combining the VGF promoter with the initiating nucleotide under-
genetic and biochemical analysis of poxvirus gene tran- lined and the italic text represents a ScaI site introduced
scription. Lysolecithin treatment of wild-type or ts mutant for ease of identification of the desired clone. The pro-
virus-infected cells yields an extract that is active in early, moter sequence in the finished clone was confirmed by
intermediate, and late gene transcription in vitro. Further- DNA sequence analysis. Accurate transcription of the
more, signal-dependent termination of early gene tran- pVGFG G-less cassette should yield an RNA of 379 nt in
scription occurs which can be enhanced by the addition length.
of pure VTF. This observation permitted the demonstra-
pG8G, containing the vaccinia virus gene G8R interme-
tion that class-specific restriction of transcription termi-
diate promoter (Baldick et al., 1992), was constructed in
nation is determined by the promoter employed in tran-
the same fashion as pVGFG, except that the sequence
scription initiation. Extracts prepared from cells infected
of the inserted oligonucleotide was 5* AGTACTCATTTA-with a ts mutant in the viral mRNA capping enzyme exhib-
ACTTTAAATAATTTACAAAAATTTAAAATA 3*. In the au-ited an appropriate mutant phenotype in vitro.
thentic G8R promoter, the 3*-terminal residue is a G, and
the 3*-terminal ATG is the gene G8 initiation codon. In
MATERIALS AND METHODS our construction, the 3*-terminal G was changed to an A
for compatibility with transcription of a G-less cassette.Cells and virus
The promoter sequence in the finished clone was con-
BSC40 cells, wild-type vaccinia virus strain WR, the firmed by DNA sequence analysis. Accurate transcription
temperature-sensitive vaccinia virus strain IHD mutant of the pG8G G-less cassette should yield an RNA of
ts9383, and the conditions for virus growth, infection, and approximately 380 nt in length.
plaque titration have been described previously (Dales pG8GS is a derivative of pG8G that contains the vac-
et al., 1978; Condit and Motyczka, 1981; Condit et al., cinia gene G8R intermediate promoter upstream of a 3*-
1983; Carpenter and DeLange, 1991). A549 cells, a hu- truncated, 188-nt G-less cassette derived from pC2AT19.
man lung carcinoma cell line, were obtained from Dr. Sue The G8R promoter and the 5* 188 nt of the pC2AT19 G-
Moyer and maintained in Dulbecco’s modified Eagle’s less cassette were PCR amplified from pG8G using the
medium (Life Technologies, Gaithersberg, MD) con- M13-40 universal sequencing primer as the upstream
taining 10% defined, supplemented bovine calf serum primer and a downstream primer which contained nucle-
(HyClone Laboratories, Inc., Logan, UT). otides 169–188 of the G-less cassette flanked with a
SmaI site, a ScaI site, and a BamHI site. The PCR-ampli-
Plasmids
fied fragment was cleaved with EcoRI (upstream) and
BamHI (downstream) and cloned into the vector portionpC2AT19 (Sawadogo and Roeder, 1985), containing a
of pC2AT19, which had also been cleaved with EcoRI375-nt G-less cassette, was obtained from Dr. Stewart
and BamHI. The SmaI site at the 3* end of the resultingShuman (Sloan Kettering Institute, New York, NY). pSB24
truncated G-less cassette serves to efficiently arrest tran-(Luo et al., 1991), which contains a synthetic vaccinia virus
scription of the G-less cassette, and the downstreamearly transcription promoter placed upstream of the 375-
nt G-less cassette in pC2AT19, was also obtained from ScaI site was used for identification of the desired clone.
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Accurate transcription of the pG8GS G-less cassette mM, and micrococcal nuclease (1 mg/ml stock solution,
15,000 units/mg; Worthington Biochemical Corp., Free-should yield an RNA of approximately 195 nt in length.
p11kGX is a derivative of pCFW10 that contains the hold, NJ) was added to a final concentration of 12 mg/
ml. Extracts were incubated at 307 for 15 min, then placedvaccinia 11k (gene F17R) late promoter upstream of a 3*-
truncated, 93-nt G-less cassette derived from pC2AT19. It on ice, and EGTA (0.2 M stock solution) was added to a
final concentration of 2 mM. Extracts were centrifugedwas constructed in exactly the same fashion as pG8GS,
except that pCFW10 was used as the template for PCR in a Beckman Microfuge 11 at a setting of 1.6 for 5 min
to pellet nuclei and cell debris. The supernatant wasamplification, and the downstream primer contained nu-
cleotides 73–93 of the pC2AT19 G-less cassette. Accu- removed and stored at 0707 in 110-ml aliquots. Extracts
are stable at 0707 for at least 6 months.rate transcription of the p11kGX G-less cassette should
yield an RNA of approximately 103 nt in length which is
In vitro transcriptionsubject to 5* polyadenylation.
To construct plasmids capable of exhibiting signal- Reactions (10 or 50 ml) contained 25 mM HEPES, pH
dependent transcription termination, a 156-bp G-less 7.4, 4.5% glycerol, 80 mM KOAc, 5 mM MgCl2 , 2.6 mM
cassette containing tandem termination sequences AAT- DTT, 1 mM ATP, 1 mM UTP, 20 mM CTP, 2.5 mCi [a-
TTTTATAATTTTTAT in the nontemplate strand was pre- 32P]CTP (3000 Ci/mmol stock), 100 mM 3*-O-Me-GTP,
pared from synthesized oligonucleotides. Plasmids 10 mg/ml DNA, and up to 60% by volume cell extract.
pSB24, pG8G, and pCFW10, containing the vaccinia virus Reactions were mixed on ice and incubated at 307C for
early, intermediate, and late promoters, respectively, 30 min. Three hundred-fifty microliters of ‘‘PK mix’’ [114
were linearized by digestion with SmaI at the 3* end of mM Tris–HCl, pH 7.5, 14 mM EDTA, 150 mM NaCl, 1.14%
the G-less cassette and the termination cassette was SDS, 114 mg/ml tRNA, 230 mg/ml proteinase K (Life Tech-
inserted. Clones containing the insert in the correct ori- nologies, Gaithersberg, MD)] was added and the reac-
entation were identified by DNA sequence analysis of tions were incubated at 377 for 30 min. Reactions were
isolated plasmid DNA and each contained the structure extracted once with an equal volume (400 ml) of phenol/
denoted in Fig. 5. chloroform. Nucleic acids were precipitated from the
aqueous phase by addition of 100 ml 10 M ammonium
Infected cell extracts for transcription acetate and 300 ml isopropanol, incubation at room tem-
perature for 30 min, and centrifugation for 10 min. Pellets
Whole-cell extracts were made by a modification of were washed once with 70% ethanol, dried, and resus-
the procedure described by Brown et al. (1983). Confluent pended in 20 ml formamide loading buffer. Samples were
100-mm dishes of A549 cells were infected with vaccinia denatured at 907, 3 min, and 10 ml was loaded on 4 or
virus at a m.o.i. of 15 and incubated at 377 for 16 hr 7% polyacrylamide urea gels in TBE. Gels were run at
unless otherwise indicated. Infected cells were placed 250 V until the xylene cyanol reached the bottom of the
on a tray of ice, and all subsequent steps were done at gel. Gels were fixed in 10% methanol, 10% acetic acid,/47. Medium was removed from the dishes and cells dried, and autoradiographed at 0707 with an intensifying
were washed once with ‘‘Kwash’’ buffer [30 mM HEPES, screen.
pH 7.4 (titrated with KOH), 150 mM sucrose, 50 mM
KOAc, 4.5 mM Mg(OAc)2]. Two milliliters of Kwash buffer Immunological techniques
containing 250 mg/ml lysolethicin (L-a-lysophosphatidyl-
Western blot analyses were performed on extracts pre-choline, palmitoyl; Sigma Biochemical Co., St. Louis, MO)
pared from wild-type and ts mutant virus-infected cellwas added to each dish, and the solution was distributed
extracts using antisera raised in rabbits against the N-over the monolayers for 2 min by gently rocking the
terminal 26 kDa of the D1R protein or the entire D12Ldishes. The lysolethicin was diluted by addition of 5 ml
protein. In order to estimate the levels of the D1R andof Kwash buffer to each dish, and the buffer was immedi-
D12L proteins in the mutant virus-infected cell extractsately aspirated from each dish. The covered dishes were
relative to the wild-type virus-infected cell extracts, West-raised at a steep angle for 4 min to drain the remaining
ern blots were performed in which a constant amount ofsolution, which was then aspirated from the dishes. Two
mutant extract was compared to serial dilutions of thehundred-fifty microliters of MEB [25 mM HEPES, pH 7.4
wild-type virus-infected cell extract.(titrated with KOH), 50 mM KOAc, 1 mM DTT, 7.5% glyc-
erol] was added to each dish. The infected cells were
Guanylyltransferase activity
scraped into this small volume of MEB and transferred
to a chilled tube. Each 100-mm dish yielded approxi- The first step in the guanylyltransferase reaction, the
formation of covalently bound GMP, was assayed asmately 350 ml of infected cells. The lysolethicin-treated
cells were triturated 5–10 times with a narrow gauge described (Niles et al., 1994). To estimate the level of
active D1R in the mutant-infected cell extract relative tohypodermic needle or a micropipettor. CaCl2 (0.1 M CaCl2
stock solution) was added to a final concentration of 1 the wild-type virus-infected cell extract, E-GMP formation
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activity in the mutant extract was compared to dilutions production of extracts (not shown). First, host cells were
compared. The African green monkey kidney cell line,of normal infected cell extract.
BSC40, has been used as host for all of the genetic
studies of vaccinia virus strain WR, but lysolethicin ex-Preparation of capping enzyme and the
methyltransferase and D1R1 – 545 domains traction of infected BSC40 cells produced extracts with
variable and often low activity. The human lung carci-
The intact capping enzyme, the methyltransferase do- noma cell line, A549, which has been used successfully
main, and D1R1 – 545 were purified from induced Esche- for production of lysolethicin extracts of Sendai-, VSV-,
richia coli, as described (Higman and Niles, 1992; Hig- and measles-infected cells (Peluso and Moyer, 1983;
man et al., 1994; Myette and Niles, 1996, respectively). Carlsen et al., 1985; Moyer et al., 1990; Horikami and
The concentration of each was estimated from the molar Moyer, 1991; Horikami et al., 1992), yielded extracts of
absorption calculated from the amino acid content by the uniformly high activity. A549 cells were therefore chosen
GCG program Peptidesort. The E1%280 of D1R
1 – 545 was cal- for all subsequent experiments. Second, the effect of
culated to be 7.4. In each case, the enzyme was purified infection time on transcription activity in extracts was
to electrophoretic homogeneity. assessed. In vitro transcription activity was not observed
at 2 hr after infection when viral early gene transcription
RESULTS in vivo is at a peak. However, both early and late in
vitro transcription activities could be observed by 7 hrPreparation of an infected cell extract that supports
postinfection and were found to be maximal between 12viral transcription
and 72 hr postinfection. Third, the effect of micrococcal
nuclease treatment on extract activity was tested. Tran-Several previously isolated conditionally lethal mu-
tants of vaccinia virus display defects in gene expression scription in crude extracts prior to removal of nuclei dem-
onstrated that elimination of micrococcal nuclease treat-which indicate that the affected gene products normally
function in viral transcription. Biochemical proof of this ment had no effect on activity. However, without micro-
coccal nuclease treatment, little if any transcriptionhypothesis and further characterization of the mutants
requires reproduction of the in vivo mutant phenotype in activity remained in the supernatant after removal of nu-
clei by centrifugation. Thus, micrococcal nuclease proba-an in vitro transcription system. To this end, a method
was sought for biochemical analysis of transcription de- bly solubilizes RNA polymerase or transcription factors
that are otherwise removed as part of a nucleoproteinfects in mutant-vaccinia-infected cells. Several factors
were considered initially. In order to readily test a number complex during centrifugation. Finally, it was observed
that initial freezing results in less than 50% loss of activity;of different mutants and infection conditions, a method
which permitted preparation of extracts on a small scale extracts are not refrozen, and extracts are stable at 0707
for at least 6 months.from infected cell monolayers was desirable. In addition,
since other viral and cellular components might be in- Several variables which could affect the in vitro tran-
scription itself were tested. The use of a G-less cassettevolved in reproduction of a particular mutant phenotype,
an extraction protocol which would result in minimal dis- in the presence of 3*-O-methyl GTP was found to be
necessary to suppress nonspecific background tran-ruption of the cellular architecture and yield as crude
an extract as possible was preferred. An appropriate scription, which otherwise obscures the signal from pro-
moter-specific transcription (not shown). Titration of 3*-procedure was found in the published work of Brown
et al. (1983), who used lysolethicin permeabilization of O-methyl GTP revealed that a minimum of 10 mM was
required to promote efficient termination of transcriptionvaccinia virus-infected cells to produce cell extracts com-
petent for in vitro translation. Briefly, monolayer cultures at the end of the G-less cassette (not shown). Utilization
of radiolabeled CTP at concentrations lower than 10 mMof A549 cells are infected with vaccinia virus and incu-
bated until the infection is well into the late phase. In- resulted in synthesis of shorter than normal transcripts
(not shown). The effect of KOAc, NaCl, NaOAc, andfected cells are then permeabilized by brief exposure to
lysolethicin in an iso-osmotic sucrose solution. Perme- NH4OAc, in the range of 30 to 230 mM, was tested (Fig.
1). All salts, particularly NaCl and NaOAc, were inhibitoryabilized cells are harvested in a hypotonic solution and
treated with micrococcal nuclease, and nuclei are re- at concentrations in excess of 100 mM, consistent with
previous monovalent cation titrations done on transcrip-moved by low-speed centrifugation to yield a transcrip-
tionally active supernatant which can be stored frozen tion assayed in vitro from early (Luo et al., 1991; Hagler
and Shuman, 1992) or late (Schwer and Stunnenberg,(Materials and Methods). The extract is active in tran-
scription of each of three reference vaccinia virus pro- 1988) promoters. In the case of the early promoters, the
results of Luo et al. (1991) and Hagler and Shuman (1992)moters representing each gene class, early, intermedi-
ate, and late (Figs. 1–4). A single 10-cm dish of infected show that inhibition by NaCl acts at the level of initiation
while elongating RNA polymerase is relatively insensitivecells yields enough extract for 10–20 50-ml reactions.
Several variables were tested which could affect the to salt. In the system described here, transcription from
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FIG. 1. Determination of salt optima in the in vitro transcription reac- FIG. 2. Determination of optimum DNA concentration in the in vitro
tion. Reactions contained 10 mg/ml each pVGFG (E, 380-nt transcript), transcription reaction. Reactions contained pVGFG (E, 380-nt tran-
pG8GS (I, 195-nt transcript), and p11KGX (L, 105-nt transcript); 30 mM script), pG8G (I, 380-nt transcript), pCFW10 (L, 380-nt transcript), or a
KOAc (contributed by the extract); optimum concentrations of other mixture (mix) of pVGFG (E, 380-nt transcript), pG8GS (I, 195-nt tran-
reagents; and added salt as indicated at the top. Reaction products script), and p11KGX (L, 105-nt transcript), and optimum concentrations
were separated on a 7% polyacrylamide gel, which was dried and of other reagents. The DNA concentration, in mg/ml, is indicated at the
autoradiographed for 7 days. top of each lane. In reactions containing the mixture of templates, the
concentration given is the concentration of each of the three DNAs in
the reaction. The signal observed with a mixture of 10 mg/ml each
template in this experiment is artifactually low, probably due to poorlate promoters was somewhat less salt sensitive than
sample recovery. Reaction products were separated on a 7% polyacryl-transcription initiated at early or late promoters. KOAc
amide gel, which was dried and autoradiographed for 4 days.
gave the best stimulation; 80 mM KOAc was the optimum
condition for coexpression of all three promoters. Identi-
transcription using extracts made from cells infected incal salt titrations done with optimum concentration of
the presence of the DNA replication inhibitor hydroxy-each of the individual early, intermediate, and late pro-
urea (HU), which permits early gene transcription butmoters gave identical results (not shown). MgCl2 and
prevents intermediate and late gene transcription (Fig. 4).ATP optima were also determined empirically by titration
The results showed that extracts made in the presence of(not shown). DNA titrations with templates containing
HU were incapable of initiating transcription at early andeach of the three classes of vaccinia virus promoters
late vaccinia promoters, but were enhanced in their abil-showed optimum transcription at DNA concentrations of
ity to transcribe the intermediate gene promoter. Stimula-approximately 10 mg/ml and inhibition at high concentra-
tion of intermediate promoter activity probably reflectstions of DNA (Fig. 2). The inhibition at high DNA concen-
accumulation of early gene products, which include inter-trations could be mimicked by addition of an irrelevant
mediate transcription factors, in the absence of interme-DNA, indicating that the inhibition is a nonspecific salt
diate and late gene transcription. The absence of lateor squelching effect, rather than a promoter-specific ef-
promoter activity in these extracts is consistent with thefect (not shown). Figure 2 also shows that when the
observation that three of the four known late transcriptionsystem is programmed with three different promoters,
factors are the products of intermediate genes, whoseeach driving a different length G-less cassette, the opti-
transcription is inhibited in the presence of HU. The ab-mum total DNA concentration for the template mixture is
similar to the optimum DNA concentration for each of
the individual templates. Extract titration revealed an op-
timum of 20–30 ml of extract per 50-ml reaction, regard-
less of DNA template used (Fig. 3). The extract optimum
and absolute activity of each promoter is subject to slight
variation when different extracts are compared.
Early gene transcription in vitro requires newly
synthesized late proteins
FIG. 3. Titration of extract in the in vitro reaction. Reactions (50 ml)
contained pVGFG (E, 380-nt transcript), pG8G (I, 380-nt transcript), orPreliminary infection time course experiments de-
pCFW10 (L, 380-nt transcript) DNA and 10, 20, or 30 ml of extract asscribed above suggested that the early transcription ac-
indicated at the top, and optimum concentrations of other reagents.
tivity present in extracts is due to the synthesis of pro- Two different extracts are compared. Reaction products were sepa-
teins late during infection rather than to enzymes present rated on a 7% polyacrylamide gel, which was dried and autoradio-
graphed for 16 hr.in infecting virions. To confirm this hypothesis we tested
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Transcription initiated at intermediate or late
promoters fails to terminate in vitro
In vivo, signal-dependent transcription termination is
restricted to the early class of genes (Wittek et al., 1980).
At intermediate or late times in infection, the TTTTTNT
signal is disregarded. The mechanism of class restriction
of transcription termination is unknown. However, one
FIG. 4. The effect of hydroxyurea on infected cell extracts. Extracts
could speculate that VTF is inactivated or sequesteredwere made from cells infected in the presence of 10 mM hydroxyurea
at late times or that the RNA polymerase employed at(/HU) or in the absence of drug (0 drug). Reactions contained 3, 10,
intermediate or late times is itself insensitive to VTF.or 30 mg/ml of pVGFG (E, 380-nt transcript), pG8G (I, 380-nt transcript),
or pCFW10 (L, 380-nt transcript) DNA as indicated at the top, and In order to determine whether transcription initiated at
optimum concentrations of other reagents. Reaction products were intermediate or late gene promoters is susceptible to
separated on a 7% polyacrylamide gel, which was dried and autoradio-
VTF-dependent termination in vitro, an extract preparedgraphed for 16 hr.
from wild-type virus-infected cells was programmed with
plasmid DNA containing each promoter class, and RNA
was prepared and separated by gel electrophoresissence of early promoter activity in these extracts shows
(Figs. 5B and 5C). Transcription initiated at an intermedi-that the VETF and H4L-containing RNA polymerase are
ate gene promoter is not terminated by VTF at any levelnot provided by the infecting virions and suggests that
tested, extending the observation of Vos et al. (1991).each must be synthesized from late mRNA. Similar con-
Likewise, transcription initiated at a late promoter is alsoclusions were drawn by Ahn and Moss (1992) who as-
insensitive to VTF-dependent termination (Fig. 5C). Tosayed transcription activity in extracts prepared from cy-
test whether a pool of inactive VTF is present in the latetosine arabinoside-treated cells. It is noteworthy that the
infected cell extract, Western blot analysis was con-VETF activity observed in vitro is suppressed in vivo by
ducted employing antibodies raised against the D12Lunknown mechanisms, since in general early vaccinia
subunit of VTF (Niles et al., 1989). By comparison of thegenes are not transcribed late during infection. Our re-
intensity of the VTF in the extract to known VTF standardssults in this regard are consistent with previously re-
it was determined that the level of termination activityported experiments (Zhang et al., 1994).
Signal-dependent termination of transcription in
infected cell extracts
To test the ability of the extracts to support early gene
transcription termination, the plasmid templates were
modified to contain an additional G-less region pos-
sessing a tandem early gene transcription termination
signal. Synthesis of a transcript that extends from the
initiation site to the end of the G-less cassette would
yield a product of about 540 bases in length. Signal-
dependent termination of transcription would be ex-
pected to produce a family of RNA products about 450
bases in length. Transcription of pSB24-term was carried
out in the presence of various levels of exogenously
added VTF and the RNA products were analyzed by gel
electrophoresis (Fig. 5). In the case of the early-promoter-
containing template, pSB24-term (Fig. 5A), two products
are observed. The larger is the full length 540-base
runthrough transcript. A minor smaller species is of the
size expected for termination products. As the level of
exogenous VTF is elevated there is a decrease in the FIG. 5. Promoter-dependent termination of transcription. Transcrip-
tion reactions were carried out in 10-ml volumes containing a templateyield of the 540-base RNA and a concomitant increase
possessing an early, intermediate, or late gene promoter and a G-lessin the termination product. This confirms the observation
cassette harboring a tandem termination signal. Reactions were donereported previously that VTF is a required termination
in the absence or presence of varying amounts of VTF. VTF, vaccinia
factor (Shuman et al., 1987). It also demonstrates that termination factor (mRNA capping enzyme); RT, readthrough transcript;
the level of endogenous termination factor is limiting in T, terminated transcript; E, products produced by transcription of
pSB24-term in the presence of VTF.this infected cell extract.
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gene transcription. Addition of capping enzyme restores
the synthesis of RNA from a template containing the
intermediate promoter, providing genetic evidence for
the requirement of the D12L subunit for intermediate
gene transcription. The 407 ts mutant virus-infected cell
extracts also lack late transcription activity (data not
shown).
FIG. 6. Effect of a ts mutation in D12L on early gene transcription VTF is unstable in ts9383-infected cell extracts
termination. An extract was prepared from cells infected at either 31
or 407 with a virus possessing a ts mutation in gene D12L. Transcription In several instances, vaccinia virus ts mutant proteins
termination activity was measured in each extract using the pSB24-term synthesized at the nonpermissive temperature are rap-
template, in the absence or presence of additional VTF. IT, infection
idly degraded (Dyster and Niles, 1991; Christen et al.,temperature, extracts employed were prepared from cells infected at
1992). In order to assess the stability of the D1R and31 or 407; R, readthrough transcript; T, termination product; M, marker
D12L subunits in ts9383-infected cells, Western blot anal-lane, marker molecular weights are noted at the left.
ysis was conducted and the results are presented in Fig.
8A. The level of D12L is equivalent in extracts prepared
observed in the first lane of Fig. 5A is roughly consistent from cells infected with wild-type virus at either tempera-
with the amount of cross-reacting material in the infected ture and in an extract of cells infected at the permissive
cell extract (data not shown), demonstrating that the late temperature with ts mutant virus. However, D12L is
infected cell extract does not contain a large pool of barely detectable, 10% or less of normal, in an extract of
sequestered or inactivated VTF. cells infected at 407 with the ts9383. When the D1R sub-
unit is analyzed, it can be seen that D1R is reduced to
Analysis of transcription termination in extracts about 40 to 50% of normal in the extract of cells infected
prepared from a ts mutation in the D12L subunit of with ts9383, at the nonpermissive temperature. Based on
VTF these observations we can conclude that while the 407
ts9383 extract is nearly devoid of the D12L subunit, aCarpenter and DeLange (1991) mapped the ts9383 mu-
significant amount of D1R remains. To determinetation to the D12L subunit of VTF. In order to ascertain
whether the remaining D1R subunit retains enzymaticwhether the ts phenotype could be replicated in vitro,
activity, the first step of the guanylyltransferase reactionextracts were prepared from cells infected at 31 or 407,
was measured. In Fig. 8B, it can be seen that the extractthe permissive and nonpermissive temperatures, respec-
prepared from cells infected with ts9383 at 407 retainedtively. When programmed with pSB24-term, the 317 ex-
E-GMP formation activity. Quantitation by densitometrytract supported synthesis of both the runthrough tran-
showed that the mutant extract retained about 36% ofscript and the termination product (Fig. 6). Exogenously
the wild-type extract activity, similar to the relative leveladded VTF enhanced the level of termination to about
of D1R protein observed in Fig. 8A. Since a substantial70%. The extract prepared from cells infected at the non-
amount of enzymatically active D1R remains in thepermissive temperature directed the synthesis of only the
ts9383-infected cell extract we can conclude that in these540-nucleotide runthrough RNA product, demonstrating
assays, the D1R subunit alone is incapable of mediatingthat this extract was devoid of VTF activity. Addition of
either early gene transcription termination, consistentpure VTF restored termination activity, providing further
evidence that the small D12L subunit is essential for
transcription termination, in agreement with the in vitro
results of Luo et al. (1995).
The D12L subunit is required for intermediate gene
transcription initiation
The mRNA capping enzyme has been shown to be an
essential intermediate gene transcription factor (Vos et
al., 1991; Harris et al., 1993). In order to assess whether
the D12L subunit is required for intermediate gene tran- FIG. 7. Intermediate gene transcription requires mRNA capping enzyme
in vitro. Extracts were prepared from cells infected at 407 with a virusscription initiation, extracts prepared from ts mutant virus
containing a ts mutation in gene D12L. Transcription reactions were con-cells infected at 407 were programmed with pG8G-term,
ducted in the presence of pG8G-term (intermediate) or pSB24-term (early),and transcription was carried out in the presence or ab-
in the absence or presence of added VTF (mRNA capping enzyme). Tem-
sence of capping enzyme (VTF) (Fig. 7). In the absence plate, Inter possesses an intermediate gene promoter, E possesses an
of exogenously added capping enzyme, the ts mutant early gene promoter; M, molecular weight markers, weights noted at the
left; R, readthrough transcript; T, termination product.virus-infected cell extract does not support intermediate
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FIG. 8. Concentration of D1R and D12L subunits and guanylyltransferaes activity in extracts prepared from cells infected at the permissive and
nonpermissive temperatures with wild-type and ts9383 virus. (A) Western blot analysis of D1R and D12L. Ten microliters of extracts prepared from
cells infected with either wild-type virus or ts9383 at either 31 or 407, or 2.5 or 5 pmol of capping enzyme (ce), were separated by gel electrophoresis,
transferred to nitrocellulose, and incubated with antisera raised against either the N-terminal region of D1R or the entire D12L protein. (B) Guanylyl-
transferase activity. One to three microliters of wild-type infected-cell extract or 3 ml of ts9383 virus-infected cell extract was incubated with 1.2 mM
[a-32P]GTP (800 Ci/mmol) for 1 min at 07. The samples were quenched with SDS sample buffer, separated by gel electrophoresis, and analyzed by
autoradiography.
with the observations of Luo et al. (1995), or intermediate able to mediate early gene transcription termination in
vitro. Furthermore, addition of either subdomain fails togene transcription initiation. Furthermore, these results
suggest but do not prove that the D12L subunit plays diminish termination activity mediated by the endoge-
nous VTF, demonstrating that each subdomain is incapa-a direct role in both processes, either through a direct
interaction or by maintaining the D1R subunit in an active ble of acting as a dominant negative inhibitor. At very
high concentrations, D1R1 – 545 inhibits all transcription byconformation.
an unknown mechanism.
Active subdomains of the mRNA capping enzyme do
not support either early gene transcription
termination or intermediate gene transcription
initiation
The mRNA capping enzyme (VTF) consists of two func-
tional domains. The N-terminal region of D1R harbors the
mRNA triphosphatase and guanylyltransferase activities
(Shuman, 1989, 1990; Shuman and Morham, 1990; Hig-
man and Niles, 1992). A second domain containing the
(guanosine-7-)methyltransferase activity consists of the
small D12L subunit and the carboxyl-terminal domain of
D1R (Higman et al., 1994; Mao and Shuman, 1994). Each
domain can be expressed in E. coli and isolated as two
kinetically and functionally independent units (Higman et
al., 1994; Myette and Niles, 1996). To assess whether
the subdomains are capable of supporting termination
of transcription initiated at an early promoter, wild-type
extracts were programmed with pSB24-term in the ab-
sence or presence of various levels of VTF or of either
subdomain (Fig. 9). As seen in Fig. 5, in the absence
of exogenous VTF, both a runthrough and a terminated
transcript are synthesized. Addition of VTF enhances the
FIG. 9. Active mRNA capping enzyme subdomains lack transcriptionsynthesis of the termination product. The addition of nei-
termination activity. Transcription was conducted in 10-ml reactions
ther D1R1 – 545 nor the methyltransferase domain in- containing pSB24-term as the template, in the absence or presence of
creases the production of the termination product, dem- varying levels of capping enzyme derivatives. Top, VTF (the intact mRNA
capping enzyme); middle, Mtase (the subdomain that exhibits (nucleo-onstrating that neither is capable alone of mediating
side-7)methyltransferase activity containing the carboxyl-terminal do-early gene transcription termination. Addition of both
main of the D1R subunit from amino acids 497 to 844 and the intactsubdomains together also fails to support termination
D12L subunit); bottom, D11–545 (the subdomain of the D1R subunit from
(data not shown). These observations confirm and extend amino acids 1 to 545, possessing the ATPase, mRNA triphosphatase,
the results of Luo et al. (1995) who showed that neither and guanylyltransferase active sites). RT, readthrough transcript; T,
termination product.subunit alone nor the methyltransferase domain were
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infected-cell extracts that support faithful gene transcrip-
tion in vitro. Specific transcription initiation of plasmids
containing a G-less cassette flanked by an early interme-
diate or late gene promoter was observed. Conditions for
optimal transcription of each plasmid were determined
empirically.
In addition to RNA polymerase, transcription initiation
at an early promoter requires both a specific heterodi-
meric protein, VETF (Broyles et al., 1988), which is pack-
aged in the virion core, and the H4L protein, a subunit
of the virion RNA polymerase (Ahn and Moss, 1992). Both
H4L and the two subunits of VETF are synthesized at
late times in infection. Analysis of extracts prepared from
cells infected with virus in the presence of a DNA replica-
tion inhibitor, hydroxyurea, demonstrates that the H4L
and VETF employed in early gene transcription are newly
synthesized rather than released from infecting virus
cores, in agreement with the observations of Ahn and
Moss (1992). The use of hydroxyurea also substantially
increases the intermediate gene transcription activityFIG. 10. Effect of mRNA capping enzyme subdomains on intermedi-
found in the cell extract. It is interesting that while ex-ate gene transcription. (A) Transcription analyses were carried out in
10-ml reactions containing pSB24-term DNA (lanes 1 and 2) or pG8G- tracts display early promoter specific transcription activ-
term DNA (lanes 3 to 10) and varying levels of CE, mRNA capping ity in vitro, few if any early genes are transcribed in vivo
enzyme, or the D11–545 or MTase subdomains. (B) Inhibition of capping at late times after infection when the extracts are made.
enzyme-dependent intermediate gene transcription by the mRNA cap-
Thus, the early transcription activity present late duringping enzyme subdomains was tested in transcription reactions con-
infection in vivo is somehow suppressed, and this sup-taining pG8G-term DNA and varying levels of mRNA capping enzyme
or the capping enzyme subdomains. The amount of each protein added pression is unmasked when extracts are made. The
is noted at the top of each lane in picomoles. mechanism of suppression of early transcription in vivo
is obscure; one possibility is that packaging of the early
transcription apparatus into maturing virions suppresses
To test whether either subdomain is able to support
early transcription late during infection.
initiation of intermediate gene transcription, extracts pre-
Template plasmids were altered to contain an extended
pared from 407 ts mutant virus infected cells were pro-
G-less region harboring tandem transcription termination
grammed with pG8-term in the presence or absence of
signals. Wild-type virus-infected-cell extracts were shown
VTF or one of the subdomains (Figs. 10A and 10B). In
to support limited termination of transcription initiated at
the absence of added VTF, there was no intermediate
an early promoter. The extent of termination observed was
gene transcription. However, added VTF permitted tran-
dependent on the amount of exogenously added VTF, indi-
scription from pG8G-term. Neither subdomain alone nor
cating that the level of active VTF is limiting in the extract.
both together supported intermediate gene transcription
VTF-dependent termination was found to be limited to
in vitro. To ascertain whether either subdomain was ca-
transcription initiated at an early promoter; that is, tran-
pable of acting as a dominant negative effector of inter-
scription initiated at an intermediate or late promoter does
mediate gene transcription, the reaction was conducted
not respond to VTF. This observation is consistent with in
in the presence of VTF and differing levels of D1R1 – 545
vivo mapping results that demonstrated that only early
or the methyltransferase domain (Fig. 10B). While neither
transcripts possess easily defined 3* termini (Wittek et al.,
subdomain was capable of supporting transcription initi-
1980). Western blot analysis, carried out to quantify the
ation from an intermediate promoter, the D1R1 – 545 acted
amount of endogenous VTF in the extract, showed that a
as a potent inhibitor of VTF activity while the methyltrans-
pool of inactivated VTF does not exist which might account
ferase domain was a much weaker inhibitor.
for the inability of VTF to terminate transcription initiated
at intermediate or late promoters in vivo. Furthermore,
DISCUSSION
since addition of picomole amounts of VTF results in effi-
cient termination in vitro, there is no support for a systemTemperature-sensitive mutations have been isolated
in a variety of vaccinia virus genes that encode proteins for rapid inactivation of VTF at late times in infection. Since
VTF does not have to be present at the time of transcrip-known to play a role in viral transcription and mRNA
processing. In order to understand the biochemical basis tion initiation but rather it can terminate transcription of
preinitiated paused complexes (Hagler et al., 1994), thereof these mutant phenotypes, a method was developed
for the rapid preparation of wild-type and mutant virus- is no evidence that the promoter itself or VETF plays an
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essential role in generating a termination-competent RNA genetic evidence in confirmation of the known role for
the capping enzyme in both activities. More importantly,polymerase. Both genetic (Ensinger, 1987; Hooda-Dhingra
et al., 1989, 1990; Thompson et al., 1989) and biochemical this approach provides a convenient null extract to ana-
lyze the activity of capping enzyme mutants in both earlyevidence indicate that the species of RNA polymerase
employed at early times in infection is not identical to that gene transcription termination and intermediate gene
transcription initiation.used at later times. It was recently shown that a portion
of the virion or early RNA polymerase possesses a unique Interestingly, in vivo, the D12L ts mutant displayed no
apparent defects in either early transcription terminationadditional subunit, the product of the H4L gene (Ahn and
Moss, 1992; Ahn et al., 1994; Kane and Shuman, 1992). or intermediate transcription initiation, but rather was de-
fective in telomere resolution and morphogenesis (DalesRNA polymerase containing the H4L protein preferentially
initiates at early promoters, while RNA polymerase lacking et al., 1978; Carpenter and DeLange, 1991). Thus the in
vitro phenotype of this mutant differs significantly fromthe H4L protein initiates transcription only at intermediate
and late promoters (Ahn and Moss, 1992; Ahn et al., 1994; the in vivo phenotype, and the in vitro phenotype is more
consistent with the known activities of the D12L protein.Kane and Shuman, 1992; Zhang et al., 1994; Wright and
Coroneos, 1995). Immunological evidence demonstrates This observation suggests that the in vivo phenotype of
a ts mutant may sometimes be misleading, and that anal-that the H4 subunit remains associated with the elongat-
ing RNA polymerase molecule (Deng and Shuman, 1994). ysis of mutant extracts in vitro may be a useful supple-
ment to understanding the true biochemical conse-One appealing model proposes that the H4L subunit of
the early RNA polymerase is an essential cofactor em- quences of mutation of a given gene. It must be kept in
mind that the in vivo observation that normal virus proteinployed in early gene transcription termination.
The mRNA capping enzyme (VTF) can be separated synthesis was maintained at the nonpermissive tempera-
ture in ts9383-infected cells, reported by Carpenter andinto two active subdomains, one possessing the ATPase,
mRNA triphosphatase, and guanylyltransferase activities DeLange (1991), was obtained during the initial 12 hr of
infection. Our results were obtained employing extractsand the other possessing the (nucleoside-7-)methyltrans-
ferase active site (Shuman, 1989, 1990; Shuman and Mor- prepared from cells infected for 20 hr at the nonpermis-
sive temperature.ham, 1990; Higman and Niles, 1992; Higman et al., 1994;
Myette and Niles, 1996). Our results show that neither
subdomain alone is capable of supporting termination of ACKNOWLEDGMENTS
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